The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Burlev V.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation Federal;
Uppsala University

Mezhevitinova E.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of the Ministry of Healthcare of Russian Federation

Ilyasova N.A.

Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology;
Women’s and Children’s Health Rudbeck laboratory of the Uppsala University

Nabieva K.R.

Women’s consultation MBUZ «Domodedovo Central City Hospital»

Intermenstrual spotting and angiogenic effects of contraception with a combined hormonal estrogen-gestagenic drug

Authors:

Burlev V.A., Mezhevitinova E.A., Ilyasova N.A., Nabieva K.R.

More about the authors

Journal: Russian Journal of Human Reproduction. 2021;27(2): 90‑100

Views: 8913

Downloaded: 164


To cite this article:

Burlev VA, Mezhevitinova EA, Ilyasova NA, Nabieva KR. Intermenstrual spotting and angiogenic effects of contraception with a combined hormonal estrogen-gestagenic drug. Russian Journal of Human Reproduction. 2021;27(2):90‑100. (In Russ.)
https://doi.org/10.17116/repro20212702190

Recommended articles:
Pecu­liarities of angiogenesis in clear cell renal cancer. Russian Journal of Archive of Pathology. 2024;(4):64-70

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.